Position in DCTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$225,466
-$212,187 QoQ
Shares Held
24,296
-43.9% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DCTH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $24,376,191 across 19 Medical Devices names. DCTH ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
47,958 | $15,747,968 | |
| 2 | LMRI |
Lumexa Imaging Holdings, Inc.
|
299,491 | $2,575,622 | |
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
7,753 | $2,161,148 | |
| 4 | MASI |
Masimo Corp
|
4,732 | $841,680 | |
| 5 | AORT |
Artivion, Inc.
|
11,610 | $425,158 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
5,136 | $365,580 | |
| 7 | DXCM |
Dexcom Inc
|
5,543 | $348,100 | |
| 8 | BSX |
Boston Scientific Corp
|
5,253 | $329,625 |
All Filings in DCTH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $225,466 | 24,296 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $437,653 | 43,332 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $358,340 | 33,334 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $228,344 | 16,790 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $222,978 | 17,516 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $449,405 | 37,326 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $276,417 | 30,611 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||